Knee Osteoarthritis Clinical Trial
Official title:
Determining the Impact of a New Physiotherapist-Led Primary Care Model for Hip and Knee Pain - A Pilot Cluster Randomized Controlled Trial
This is a pilot cluster randomized controlled trial to to evaluate the individual and health system impacts of implementing a new physiotherapist-led primary care model for hip and knee pain in Canada.
Status | Recruiting |
Enrollment | 263 |
Est. completion date | February 16, 2025 |
Est. primary completion date | February 16, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - Adults >= 19 years who ask to book a primary care visits where the primary reason is for hip or knee pain of any duration. Exclusion Criteria: - Cannot understand, read, and write English - Known cancer causing hip or knee pain |
Country | Name | City | State |
---|---|---|---|
Canada | Queen's University | Kingston | Ontario |
Lead Sponsor | Collaborator |
---|---|
Jordan Miller, PT, PhD | Canadian Institutes of Health Research (CIHR), The Arthritis Society, Canada |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Baseline Characteristics | To describe the study population, the investigators will capture the following through the survey: age, sex, gender, duration of musculoskeletal pain, locations of pain, medications, comorbidities, current work status, income, rurality, and ethnicity. | Baseline | |
Other | Comorbidities | Measured at baseline using the Functional Comorbidity Index (an 18-item list of comorbidities that are associated with physical functioning). | Baseline | |
Other | Chronicity of Pain | Self-reported length of time since current and first incidence of hip or knee pain | Baseline | |
Other | Participant Treatment Fidelity | Self-report adherence to PT advice | 3 months follow-up | |
Primary | Participant Recruitment Rate | A full trial will be feasible if the investigators are able to recruit 1.5 participants per week per site over 20 weeks | 20 weeks | |
Primary | Assessment Procedures | The investigators consider =80% of all assessment items completed and a mean time for completion of =60 minutes acceptable. | 12 months | |
Primary | Retention | The investigators consider an attrition rate of =20% at 12-month follow-up successful. =35% attrition will be considered partially successful; however, additional retention strategies would be required for the full trial based on evidence that =20% attrition threatens trial validity | 12 months | |
Primary | PT Treatment Fidelity | Treatment fidelity will be measured through an audit of a PT fidelity checklist and electronic medical record (EMR) to determine the consistency of the care provided. An acceptable level of fidelity will be considered =80% for each intervention component. | 20 weeks | |
Secondary | Self-Reported Functioning | Self-report using the Lower Extremity Functional Scale (0-80 score with higher score representing higher function) | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Self-Reported Pain Intensity | Measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity. | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Health-Related Quality of Life | Measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life) | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Pain Self Efficacy | Confidence in abilities to participate in usual activities using the Pain Self Efficacy Questionnaire | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Catastrophic Thinking | Measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking) | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Fear of Movement | Measured using the Tampa Scale of Kinesiophobia (an 11-item questionnaire) | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Depression Subscale | Measured using the 2-Item Patient Health Questionnaire | Baseline and 3, 6, 9, and 12 months follow-up | |
Secondary | Global Rating of Change | Measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning and positive scores indicating an improvement of physical functioning) | 3, 6, 9, and 12 months follow-up | |
Secondary | Satisfaction with Health Care | Measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received) | 3, 6, 9, and 12 months follow-up | |
Secondary | Adverse Events | Measured using an adverse events questionnaire that asks 1) if the participant has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced. | 3, 6, 9, and 12 months follow-up | |
Secondary | Health Care Accessibility | Percentage of participants assessed within 48 hours of calling for an appointment | Baseline | |
Secondary | Health-Care Utilization - Consultations in Electronic Medical Record (EMR) | Number of consultations with primary care team members for hip or knee pain (e.g., physicians, nurse practitioners, nurses, social workers, occupational therapists) | 12 months | |
Secondary | Health-Care Utilization Survey - Visits to health professionals | Survey questions related to hip or knee pain: number of visits to health professionals outside the primary care team (e.g., chiropractors, massage therapists, occupational therapists, physiotherapists, chronic pain clinics) | 12 months | |
Secondary | Health-Care Utilization Survey - Medications | Survey questions related to hip or knee pain: number of medications taken. Includes type of medication, dose, frequency | 12 months | |
Secondary | Health-Care Utilization Survey - Walk-In Clinic Visits | Survey questions related to hip or knee pain: number of walk-in clinic visits outside of primary care centre | 12 months | |
Secondary | Health-Care Utilization Survey - Emergency Department Visits | Survey questions related to hip or knee pain: number of emergency department visits | 12 months | |
Secondary | Health-Care Utilization Survey - Inpatient Hospital Stays | Survey questions related to hip or knee pain: number of overnight hospital stays | 12 months | |
Secondary | Health-Care Utilization Survey - Surgeries, Procedures, Injections | Survey questions related to hip or knee pain: number of surgeries, procedures, and injections | 12 months | |
Secondary | Health-Care Utilization Survey - Specialist Visits | Survey questions related to hip or knee pain: number of visits to specialists | 12 months | |
Secondary | Health-Care Utilization Survey - Diagnostic Imaging | Survey questions related to hip or knee pain: number of diagnostic images received | 12 months | |
Secondary | Process Outcome - Medications Prescibed | Collected from the EMR: medications prescribed for hip or knee pain. Includes the type of medication prescribed | 12 months | |
Secondary | Process Outcome - Diagnostic Imaging Ordered | Collected from the EMR: diagnostic images ordered for hip or knee pain | 12 months | |
Secondary | Process Outcome - Exercises Prescribed | Collected from the EMR: exercises prescribed for hip or knee pain | 12 months | |
Secondary | Process Outcome - Education Provided | Collected from the EMR: education provided for hip or knee pain | 12 months | |
Secondary | Process Outcome - Referrals to other health care providers (HCPs) | Collected from the EMR: referrals to other HCPs (both internal and external to the primary health care team) for hip or knee pain | 12 months | |
Secondary | Process Outcome - Primary Care Visits | Collected from the EMR: visits to the primary care team for hip or knee pain | 12 months | |
Secondary | Process Outcome - Notes to Employers or Insurers | Collected from the EMR: notes provided to employers or insurers for hip or knee pain | 12 months | |
Secondary | Self-Report Time Lost | Self-reported time lost from work, volunteering, homemaking, and educational activities | 12 months | |
Secondary | Assistance Needed | Self-reported assistance needed, due to hip or knee pain, for self-care, housework, shopping, or transportation | 12 months | |
Secondary | Extra Expenses | Any extra expenses incurred as a result of hip or knee pain. Self-report | 12 months | |
Secondary | Cost Outcomes | Costs associated with all health utilization, self-reported time lost, assistance needed, and extra expenses. Will be presented as aggregate and time-specific costs | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04651673 -
Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
|
||
Completed |
NCT05677399 -
Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise.
|
N/A | |
Active, not recruiting |
NCT04043819 -
Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis
|
Phase 1 | |
Recruiting |
NCT06000410 -
A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee
|
Phase 3 | |
Completed |
NCT05014542 -
Needling Techniques for Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05892133 -
Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05528965 -
Parallel Versus Perpendicular Technique for Genicular Radiofrequency
|
N/A | |
Active, not recruiting |
NCT03472300 -
Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
|
||
Active, not recruiting |
NCT02003976 -
A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone
|
N/A | |
Active, not recruiting |
NCT04017533 -
Stability of Uncemented Medially Stabilized TKA
|
N/A | |
Completed |
NCT04779164 -
The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT04006314 -
Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05423587 -
Genicular Artery Embolisation for Knee Osteoarthritis II
|
N/A | |
Enrolling by invitation |
NCT04145401 -
Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
|
||
Active, not recruiting |
NCT03781843 -
Effects of Genicular Nerve Block in Knee Osteoarthritis
|
N/A | |
Completed |
NCT05974501 -
Pre vs Post Block in Total Knee Arthroplasty (TKA)
|
Phase 4 | |
Completed |
NCT05324163 -
Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis
|
Phase 3 | |
Completed |
NCT05529914 -
Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT05693493 -
Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA?
|
N/A | |
Not yet recruiting |
NCT05510648 -
Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis
|
N/A |